Florence Lefranc
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 24
- Neurology top 1%
- Vascular Malformations Diagnosis and Treatment 8
- Pharmacology top 0.5%
- Immunology top 2%
- Galectins and Cancer Biology 21
- Epidemiology top 2%
- Meningioma and schwannoma management 13
-
- Signaling Pathways in Disease 13
-
- Chemical synthesis and alkaloids 9
-
- Brain Metastases and Treatment 8
-
- Cancer Mechanisms and Therapy 8
- Co-authors
- Róbert KissJacques BrotchiVéronique MathieuIsabelle CambyMichael WellerMarie Le MercierPantelis StavrinouRoland Goldbrunner
- Cited by
- GeneticsNeurologyPharmacology
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Cancer (1 paper)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Florence Lefranc
108 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Genetics 1.0k
- Neurology 1.1k
- Pharmacology 514
- Immunology 1.2k
- Epidemiology 1.4k
Countries citing papers authored by Florence Lefranc
This map shows the geographic impact of Florence Lefranc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Lefranc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Lefranc more than expected).
Fields of papers citing papers by Florence Lefranc
This network shows the impact of papers produced by Florence Lefranc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Lefranc. The network helps show where Florence Lefranc may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Florence Lefranc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2022 | 2 | |
| 3 | EANO guideline on the diagnosis and management of meningiomasbreakdown → | 2021 | 350 |
| 4 | EANO guideline on the diagnosis and treatment of vestibular schwannomabreakdown → | 2019 | 230 |
| 5 | 2017 | 114 | |
| 6 | 2016 | 133 | |
| 7 | 2015 | 36 | |
| 8 | 2009 | 89 | |
| 9 | 2009 | 18 | |
| 10 | Cardiotonic steroids: Revealed by cardiology, hoped for potential in oncology. | 2008 | 1 |
| 11 | 2008 | 81 | |
| 12 | 2008 | 32 | |
| 13 | 2008 | 54 | |
| 14 | 2008 | 24 | |
| 15 | 2008 | 27 | |
| 16 | 2006 | 87 | |
| 17 | 2006 | 112 | |
| 18 | 2003 | 18 | |
| 19 | 2003 | 24 | |
| 20 | 2002 | 20 |
About Florence Lefranc
Florence Lefranc is a scholar working on Genetics, Neurology and Immunology, having authored 108 papers that have together received 6.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (24 papers), Galectins and Cancer Biology (21 papers), Meningioma and schwannoma management (13 papers), Signaling Pathways in Disease (13 papers), Chemical synthesis and alkaloids (9 papers), Brain Metastases and Treatment (8 papers), Vascular Malformations Diagnosis and Treatment (8 papers) and Cancer Mechanisms and Therapy (8 papers). The work is most often cited by research in Genetics (1.0k citations), Neurology (1.1k citations) and Pharmacology (514 citations). Florence Lefranc has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Róbert Kiss, Jacques Brotchi, Véronique Mathieu, Isabelle Camby, Michael Weller, Marie Le Mercier, Pantelis Stavrinou, Roland Goldbrunner, Kita Sallabanda and Morten Lund‐Johansen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.